$561 Million is the total value of Iguana Healthcare Management, LLC's 151 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 71.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $28,376,000 | +314.4% | 400,000 | +185.7% | 5.06% | +81.6% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $23,432,000 | +1797.3% | 650,000 | +622.2% | 4.18% | +732.1% |
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $22,104,000 | +83.6% | 170,000 | +70.0% | 3.94% | -19.5% |
| BIIB | Buy | BIOGEN INC | $20,347,000 | +274.0% | 65,000 | +188.9% | 3.63% | +63.9% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $18,382,000 | +214.9% | 150,000 | +200.0% | 3.28% | +38.0% |
| AMGN | Buy | AMGEN INC | $18,350,000 | +244.6% | 110,000 | +214.3% | 3.27% | +51.0% |
| New | GW PHARMACEUTICALS PLCput | $17,254,000 | – | 130,000 | +100.0% | 3.08% | – | |
| PFE | Buy | PFIZER INC | $16,936,000 | +140.5% | 500,000 | +150.0% | 3.02% | +5.4% |
| OMED | Buy | ONCOMED PHARMACEUTICALS INC | $16,574,000 | +113.0% | 1,450,000 | +129.4% | 2.96% | -6.7% |
| New | CELGENE CORPcall | $15,679,000 | – | 150,000 | +100.0% | 2.80% | – | |
| CELG | Buy | CELGENE CORP | $15,680,000 | +27.2% | 150,000 | +20.0% | 2.80% | -44.3% |
| MDCO | Buy | MEDICINES CO | $15,096,000 | +648.1% | 400,000 | +566.7% | 2.69% | +227.8% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $14,982,000 | +201.0% | 650,000 | +116.7% | 2.67% | +31.9% |
| NUVA | Buy | NUVASIVE INC | $13,332,000 | +123.2% | 200,000 | +100.0% | 2.38% | -2.1% |
| SHPG | Buy | SHIRE PLCsponsored adr | $12,601,000 | +14.1% | 65,000 | +8.3% | 2.25% | -50.0% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $12,454,000 | +371.7% | 330,000 | +120.0% | 2.22% | +106.7% |
| MZOR | Buy | MAZOR ROBOTICS LTDsponsored ads | $10,348,000 | +187.8% | 400,000 | +100.0% | 1.84% | +26.1% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $10,166,000 | +632.9% | 150,000 | +500.0% | 1.81% | +221.3% |
| DERM | Buy | DERMIRA INC | $10,146,000 | +131.2% | 300,000 | +100.0% | 1.81% | +1.3% |
| MRK | Buy | MERCK & CO INC | $9,362,000 | +30.0% | 150,000 | +20.0% | 1.67% | -43.0% |
| GKOS | Buy | GLAUKOS CORP | $9,058,000 | +130.1% | 240,000 | +77.8% | 1.62% | +0.8% |
| EXEL | Buy | EXELIXIS INC | $8,954,000 | +227.5% | 700,000 | +100.0% | 1.60% | +43.5% |
| HWAY | Buy | HEALTHWAYS INC | $8,732,000 | +236.0% | 330,000 | +46.7% | 1.56% | +47.3% |
| New | BIOGEN INCcall | $7,826,000 | – | 25,000 | +100.0% | 1.40% | – | |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $7,420,000 | +61.9% | 300,000 | +33.3% | 1.32% | -29.0% |
| BMY | New | BRISTOL MYERS SQUIBB CO | $7,010,000 | – | 130,000 | +100.0% | 1.25% | – |
| MRUS | Buy | MERUS N V | $6,700,000 | +319.3% | 400,000 | +100.0% | 1.19% | +83.7% |
| New | GW PHARMACEUTICALS PLCcall | $6,636,000 | – | 50,000 | +100.0% | 1.18% | – | |
| Buy | CIGNA CORPORATIONcall | $6,516,000 | +103.6% | 50,000 | +100.0% | 1.16% | -10.8% | |
| NERV | Buy | MINERVA NEUROSCIENCES INC | $6,352,000 | +397.8% | 450,000 | +260.0% | 1.13% | +118.1% |
| New | LILLY ELI & COcall | $6,020,000 | – | 75,000 | +100.0% | 1.07% | – | |
| MDRX | Buy | ALLSCRIPTS HEALTHCARE SOLUTN | $5,926,000 | +86.6% | 450,000 | +80.0% | 1.06% | -18.3% |
| KTWO | Buy | K2M GROUP HLDGS INC | $5,868,000 | +170.0% | 330,000 | +135.7% | 1.05% | +18.3% |
| SPNC | Buy | SPECTRANETICS CORP | $5,520,000 | +168.2% | 220,000 | +100.0% | 0.98% | +17.6% |
| GWPH | New | GW PHARMACEUTICALS PLCads | $5,310,000 | – | 40,000 | +100.0% | 0.95% | – |
| New | GLOBAL BLOOD THERAPEUTICS INput | $5,249,000 | – | 100,000 | +100.0% | 0.94% | – | |
| PCRX | New | PACIRA PHARMACEUTICALS INC | $5,134,000 | – | 150,000 | +100.0% | 0.92% | – |
| FLML | Buy | FLAMEL TECHNOLOGIES SAsponsored adr | $4,960,000 | +515.4% | 400,000 | +433.3% | 0.88% | +169.5% |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $4,916,000 | – | 150,000 | +100.0% | 0.88% | – |
| New | AERIE PHARMACEUTICALS INCput | $4,906,000 | – | 130,000 | +100.0% | 0.88% | – | |
| LHCG | New | LHC GROUP INC | $4,794,000 | – | 130,000 | +100.0% | 0.86% | – |
| IPXL | New | IMPAX LABORATORIES INC | $4,740,000 | – | 200,000 | +100.0% | 0.84% | – |
| RTRX | New | RETROPHIN INC | $4,476,000 | – | 200,000 | +100.0% | 0.80% | – |
| BIOS | Buy | BIOSCRIP INC | $4,336,000 | +126.7% | 1,500,000 | +100.0% | 0.77% | -0.6% |
| PMC | Buy | PHARMERICA CORP | $4,210,000 | +162.6% | 150,000 | +130.8% | 0.75% | +15.0% |
| IONS | New | IONIS PHARMACEUTICALS INC | $3,664,000 | – | 100,000 | +100.0% | 0.65% | – |
| ACHC | New | ACADIA HEALTHCARE COMPANY IN | $3,468,000 | – | 70,000 | +100.0% | 0.62% | – |
| KITE | Buy | KITE PHARMA INC | $3,352,000 | +34.1% | 60,000 | +20.0% | 0.60% | -41.2% |
| OPHT | New | OPHTHOTECH CORP | $3,230,000 | – | 70,000 | +100.0% | 0.58% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $3,070,000 | – | 50,000 | +100.0% | 0.55% | – |
| XENT | Buy | INTERSECT ENT INC | $2,852,000 | +47.0% | 180,000 | +20.0% | 0.51% | -35.6% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $2,834,000 | +114.7% | 370,000 | +111.4% | 0.50% | -6.0% |
| New | PHARMERICA CORPput | $2,808,000 | – | 100,000 | +100.0% | 0.50% | – | |
| IVTY | New | INVUITY INC | $2,744,000 | – | 200,000 | +100.0% | 0.49% | – |
| ARRY | New | ARRAY BIOPHARMA INC | $2,700,000 | – | 400,000 | +100.0% | 0.48% | – |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $2,688,000 | +281.8% | 300,000 | +200.0% | 0.48% | +67.5% |
| New | FIVE PRIME THERAPEUTICS INCput | $2,612,000 | – | 50,000 | +100.0% | 0.47% | – | |
| XLRN | Buy | ACCELERON PHARMA INC | $2,534,000 | +49.1% | 70,000 | +40.0% | 0.45% | -34.6% |
| MGNX | Buy | MACROGENICS INC | $2,392,000 | +18.2% | 80,000 | +6.7% | 0.43% | -48.2% |
| New | GILEAD SCIENCES INCcall | $2,374,000 | – | 30,000 | +100.0% | 0.42% | – | |
| ADMA | Buy | ADMA BIOLOGICS INC | $2,172,000 | +191.9% | 300,000 | +140.0% | 0.39% | +27.7% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $2,116,000 | +29.8% | 300,000 | +50.0% | 0.38% | -43.1% |
| IMMU | Buy | IMMUNOMEDICS INC | $1,950,000 | +273.6% | 600,000 | +166.7% | 0.35% | +64.2% |
| CCXI | Buy | CHEMOCENTRYX INC | $1,812,000 | +168.8% | 300,000 | +100.0% | 0.32% | +17.9% |
| PRAH | New | PRA HEALTH SCIENCES INC | $1,696,000 | – | 30,000 | +100.0% | 0.30% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $1,590,000 | – | 50,000 | +100.0% | 0.28% | – |
| New | ESPERION THERAPEUTICS INC NEput | $1,386,000 | – | 100,000 | +100.0% | 0.25% | – | |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $1,108,000 | – | 80,000 | +100.0% | 0.20% | – |
| MEIP | New | MEI PHARMA INC | $1,056,000 | – | 600,000 | +100.0% | 0.19% | – |
| SCYX | Buy | SCYNEXIS INC | $968,000 | +257.2% | 250,000 | +100.0% | 0.17% | +57.3% |
| New | ONCOMED PHARMACEUTICALS INCcall | $572,000 | – | 50,000 | +100.0% | 0.10% | – | |
| New | ONCOMED PHARMACEUTICALS INCput | $572,000 | – | 50,000 | +100.0% | 0.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.